HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard H Bell Selected Research

LY 293111 (LY293111)

6/2007Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
6/2005A novel anti-pancreatic cancer agent, LY293111.
4/2005LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard H Bell Research Topics

Disease

16Pancreatic Neoplasms (Pancreatic Cancer)
07/2010 - 03/2002
14Neoplasms (Cancer)
10/2008 - 03/2002
3Inflammation (Inflammations)
03/2006 - 05/2002
3Adenocarcinoma
08/2005 - 02/2002
2Chronic Pancreatitis
10/2007 - 03/2006
2Fibrosis (Cirrhosis)
05/2002 - 02/2002
2Carcinogenesis
04/2002 - 03/2002
1Polyps
10/2008
1Colonic Neoplasms (Colon Cancer)
10/2008
1Shock
04/2008
1Familial primary gastric lymphoma
10/2005
1Neoplasm Metastasis (Metastasis)
04/2005
1Chromosome Aberrations (Chromosome Abnormalities)
06/2003
1Chromosomal Instability (Chromosome Stability)
06/2003
1Pancreatitis
05/2002
1Acinar Cell Carcinoma
04/2002
1Hepatocellular Carcinoma (Hepatoma)
02/2002
1Islet Cell Adenoma (Islet Cell Tumors)
02/2002

Drug/Important Bio-Agent (IBA)

4Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
06/2007 - 04/2005
3Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
10/2008 - 06/2005
3LY 293111 (LY293111)IBA
06/2007 - 04/2005
3DNA (Deoxyribonucleic Acid)IBA
12/2006 - 09/2005
2Transforming Growth Factor beta (TGF-beta)IBA
12/2007 - 04/2007
2Leukotriene B4IBA
06/2007 - 09/2005
2OligonucleotidesIBA
04/2007 - 04/2005
2Pharmaceutical PreparationsIBA
12/2006 - 06/2005
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2005 - 06/2005
2Proteins (Proteins, Gene)FDA Link
06/2005 - 05/2002
2GemcitabineFDA Link
06/2005 - 04/2005
2CollagenIBA
05/2002 - 02/2002
1Frondanol-A5PIBA
07/2010
1zileuton (Zyflo)FDA Link
10/2008
1RetinoidsIBA
12/2007
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2007
1Transforming Growth Factor beta2IBA
12/2007
1ResveratrolIBA
04/2007
1CytokinesIBA
04/2007
1ApigeninIBA
12/2006
1FlavonoidsIBA
12/2006
1Cyclin BIBA
12/2006
1Acetates (Acetic Acid Esters)FDA Link
08/2006
1Peptides (Polypeptides)IBA
02/2006
1sansalvamide AIBA
02/2006
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2005
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2005
1ThymidineIBA
09/2005
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
08/2005
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2005
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2005
1PPAR gammaIBA
06/2005
15-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
06/2005
1LeukotrienesIBA
06/2005
1EnzymesIBA
06/2005
1enhanced green fluorescent proteinIBA
04/2005
1Phosphotransferases (Kinase)IBA
10/2004
1Tissue Inhibitor of Metalloproteinase-1IBA
10/2004
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2003
1Explosive Agents (Explosives)IBA
05/2003
1CeruletideIBA
05/2002
1Matrix Metalloproteinases (MMPs)IBA
05/2002
1GastrinsIBA
04/2002
1Peptide Hormones (Polypeptide Hormones)IBA
04/2002
1AzaserineIBA
04/2002
1Cholecystokinin B ReceptorIBA
03/2002
1Formaldehyde (Formol)FDA Link
02/2002
1von Willebrand FactorIBA
02/2002
1ParaffinIBA
02/2002
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
02/2002
1ProcollagenIBA
02/2002

Therapy/Procedure

5Therapeutics
07/2010 - 05/2003
4Pancreaticoduodenectomy
10/2007 - 02/2002
1Stents
04/2008
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
04/2008
1Gastrectomy
10/2005
1Chemoprevention
07/2005
1Operative Surgical Procedures
04/2005